跳至主要内容
临床试验/CTRI/2021/12/038506
CTRI/2021/12/038506已完成未知

â?? EVALUATION OF BIOLOGICAL, MECHANICAL AND PATIENT REPORTED PARAMETERS ASSOCIATED WITH ANGULATED SCREW CHANNEL ABUTMENTS AND MULTI UNIT ABUTMENTS FOR FABRICATION OF SCREW RETAINED IMPLANT CROWNS IN ANTERIOR ESTHETIC ZONE â?? AN IN VIVO STUDY.â?¿

Dynamic Abutment Solutions0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Patient willing for the procedure (the study is explained, including the procedure and follow up for evaluation)
  • 2)Patient that has good oral hygiene and periodontal health (patients that can follow up for evaluation)
  • 3)Sufficient mesio-distal, bucco-lingual, and interocclusal space for placement of an anatomic restoration
  • 4)Implant site free from infection

排除标准

  • 1.Medical and general contraindications for the surgical procedures
  • 2.Presence of active and uncontrolled periodontal disease
  • 3.History of local radiotherapy to the head and neck region.
  • 4.Systemic diseases (Uncontrolled diabetes, recent MI, valvular prosthesis surgery, bleeding disorders, acute renal failure, immunosuppression).
  • 5.Patients in intravenous bisphosphonate.
  • 6.Psychiatric illness
  • 7.Chronic heavy smokers
  • 8.History of head and neck irradiation in the last 6 months.

研究者

发起方
Dynamic Abutment Solutions

相似试验

进行中(未招募)
不适用
Evaluation of the quality of scars resulting from the treatment of burn sequelae with or without the use of dermal matrices
RBR-3v26fmHospital das clínicas da faculdade de medicina de Ribeirão Preto da Universidade de São Paulo
进行中(未招募)
1 期
Evaluation of the combined use of Onabotulinumtoxin A and hyaluronic acid fillers in patients with facial paralysishemifacial paralysis (3 to 6 of the House-Brackmann scale)MedDRA version: 20.1Level: LLTClassification code 10016060Term: Facial palsySystem Organ Class: 100000004852
EUCTR2018-004696-12-ITAZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA70
进行中(未招募)
不适用
Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular AdhesioVitreomacular Traction/ Symptomatic Vitreomacular AdhesionMedDRA version: 18.0Level: LLTClassification code 10070236Term: Vitreomacular adhesionSystem Organ Class: 100000004853MedDRA version: 18.0Level: LLTClassification code 10051065Term: Vitreomacular traction syndromeSystem Organ Class: 100000004853
EUCTR2013-005464-25-FRAlcon Research, Ltd.474
进行中(未招募)
不适用
Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular AdhesioVitreomacular Traction/ Symptomatic Vitreomacular AdhesionMedDRA version: 16.1Level: LLTClassification code 10070236Term: Vitreomacular adhesionSystem Organ Class: 100000004853MedDRA version: 16.1Level: LLTClassification code 10051065Term: Vitreomacular traction syndromeSystem Organ Class: 100000004853
EUCTR2013-005464-25-ESAlcon Research, Ltd.474
已完成
4 期
Assessment of Anatomical and Functional Outcomes in Patients Treated with Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion (VMT/sVMA)Vitreomacular traction10047060
NL-OMON40974Alcon Laboratories50